drugset / Trial / NCT01873378
GnRH Agonist Pretreatment in Hysteroscopic Myomectomy
RandomizedParallel-groupSingle-blindTreatment
Summary
The primary outcome of this study is to assess if the GnRHa administration before cold loop hysteroscopic myomectomy contributes to accomplish the treatment in only one surgical procedure. Moreover, we will investigate the intraoperative influence of such pharmacologic therapy in terms of distension liquid absorption and duration of the procedures.
Timeline
- Start
- 2013-01
- Primary completion
- 2015-08
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triptorelin | Other / unclassified | 3.75 mg | Intramuscular |